New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
10:36 EDTDECK, CYTK, FIO, CREE, SRPTOptions with decreasing implied volatility: CYTK SRPT FIO DECK CREE
News For CYTK;SRPT;FIO;DECK;CREE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 21, 2015
06:13 EDTDECKDeckers Outdoor recent pullback overdone, says Citigroup
Citigroup views the 18% pullback in shares of Deckers Outdoor since mid-December as overdone. Citi continues to believe UGG is better positioned versus fashion footwear peers. It lowered its price target for shares to $95 from $105 to reflect reduced multiples in the space as well as currency headwinds. Citi keeps a Buy rating on Deckers.
05:05 EDTDECKDeckers Outdoor appoints David Lafitte as COO
Deckers Brands announced the appointment of David Lafitte to COO, effective February 2. Lafitte previously served as the company's general counsel. He replaces Zohar Ziv, who retired from the company on January 16.
January 20, 2015
18:30 EDTCREEOn The Fly: After Hours Movers
Subscribe for More Information
16:09 EDTCREECree says LED lighting market still in early stages
Cree (CREE) CEO Chuck Swoboda said in the company's earnings release, "We made solid progress in Q2 with operating margin higher than targeted due to an improvement in gross margins in our lighting business. The market for LED lighting is still in the early stages, our new product pipeline is strong, sales momentum is building and our brand is growing in the market. As evidenced by our significant share repurchases in Q2, we believe we are on the right track to continue to grow the company and increase profits over the next several years." Cree peers include SemiLEDs (LEDS) and Acuity Brands (AYI). Cree shares are up 6% in after-hours trading to $34.40 after reporting better than expected Q2 results.
16:03 EDTCREECree sees Q3 EPS 21c-25c, consensus 21c
Sees Q3 revenue $395M-$415M, consensus $404.42M. Sees Q3 non-GAAP gross margin 33.5%+/-.
16:02 EDTCREECree reports Q2 EPS 33c, consensus 22c
Reports Q2 revenue $413.2M, consensus $412.12M.
15:48 EDTCREECreeJanuary weekly 32 straddle priced for 10.5% movement into Q4
Subscribe for More Information
15:21 EDTCREENotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include IBM (IBM), consensus $5.41; Netflix (NFLX), consensus 45c; CA Technologies (CA), consensus 60c; Cree (CREE), consensus 22c; Woodward (WWD), consensus 46c; Fulton Financial (FULT), consensus 21c; Advanced Micro Devices (AMD), consensus 1c; Interactive Brokers (IBKR), consensus 6c; Pinnacle Financial (PNFP), consensus 53c.
14:58 EDTCREECree technical comments ahead of earnings
There has been a pause in the dominant downtrend that began in the fall of 2013 in recent weeks that has seen basing at the $30 area. That level is the key area to watch on the downside should news be more negative than traders appear to expect. A breakdown below the $30 level could lead to a test of the 52-week low at $27.25 that was hit during the October market lows last year. If there is a positive surprise, the stock has a great deal of work ahead to turn the trend even toward neutral on a longer-term basis. Resistance levels to watch as potential upside objectives are at $35.46 and $37.26 which is the high of the range prior to the bearish gap down from early October. It would take a move above the $40 area for the stock to be back on a more bullish price path. The shares have a history of volatile reactions around earnings events with price gaps which could exceed levels noted.
14:27 EDTCREECree January weekly 31 straddle priced for 9.9% movement into Q4
11:23 EDTDECKFollow-up: Deckers Outdoor downgraded at Buckingham
Subscribe for More Information
11:16 EDTDECKDeckers Outdoor downgraded to Neutral from Buy at Buckingham
10:47 EDTDECKDeckers Outdoor down 5.3% to $81.88
Subscribe for More Information
09:45 EDTCREE, CREECree estimates lowered ahead of Q2 report, says CLSA
CLSA lowered Cree estimates ahead of Tuesday's Q2 report following checks that indicate a lack of demand improvement in China LED demand. The analyst also sees risk to increased inventory build that could lead to a cut in fab utilization and reiterates its Underperform rating.
08:46 EDTCREECree January weekly volatility elevated into Q4 and outlook
Subscribe for More Information
January 15, 2015
15:26 EDTSRPTSarepta says no safety info or comparison in BioMarin presentation
Sarepta (SRPT) said that, given the small sample size of study 201/202, the company understood the importance of providing an "extensive amount of date" in order to understand eteplirsen's treatment effect. Sarepta has reported mITT data since week 24 and has continued to provide updates on this same mITT at every timepoint, the company said. BioMarin's (BMRN) presentation on Monday focused on extension phase and excluded dose-escalation phase and results during off-treatment periods, according to Sarepta. "Sarepta has regularly reported complete 201/202 safety data on all patients. No safety information or comparison [was included] in BioMarin's Monday presentation," Sarepta wrote in slides for its presentation at the JPMorgan Healthcare Conference.
12:00 EDTCREECree January weekly volatility elevated at 104 into Q4 and outlook
Cree January call option implied volatility is at 104, February is at 55, June is at 49; compared to its 26-week average of 42 according to Track Data, suggesting large movement into the expected release of Q4 results on January 20.
07:13 EDTSRPTJPMorgan to hold a conference
Subscribe for More Information
06:16 EDTCREEIHS: LED industry faces pivotal year in 2015, DigiTimes reports
IHS says 2015 could be a pivotal year for the global LED industry due to the growing market share of Chinese LED companies throughout the value chain, reports DigiTimes. IHS adds that China vendors must overcome negative perceptions of product quality while maintaining their low pricing. Increased marketing of cloud-based msart lighting could gain mindshare in 2015. Reference Link
January 14, 2015
08:30 EDTSRPTSarepta says first patient dosed in European Phase 1/II SRP-4053 study
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use